During the past decade, UF Health Davis Cancer Pavilion and Shands Med Plaza conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UF Health Davis Cancer Pavilion and Shands Med Plaza" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "NSABP Foundation Inc" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "GlycoMimetics Incorporated" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UF Health Davis Cancer Pavilion and Shands Med Plaza" #1 collaborator was "Clovis Oncology, Inc." with 1 trials as a collaborator, "Natera, Inc." with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UF Health Davis Cancer Pavilion and Shands Med Plaza" are "Advanced Gastric Cancer" (1 trials), "Anemia, Sickle Cell" (1 trials), "Colon Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Colorectal Cancer Metastatic" (1 trials). Many other conditions were trialed in "UF Health Davis Cancer Pavilion and Shands Med Plaza" in a lesser frequency.

Most popular intervention types in "UF Health Davis Cancer Pavilion and Shands Med Plaza" are "Drug" (8 trials), "Biological" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (2 trials), "Nivolumab" (2 trials), "BMS-986205" (1 trials), "Carboplatin" (1 trials) and "Carfilzomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UF Health Davis Cancer Pavilion and Shands Med Plaza" are 9 trials for "All" genders.

Currently, there are NaN active trials in "UF Health Davis Cancer Pavilion and Shands Med Plaza". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UF Health Davis Cancer Pavilion and Shands Med Plaza, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UF Health Davis Cancer Pavilion and Shands Med Plaza, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".